Profil
Heikki Joensuu is currently the Vice President-Therapy Area Oncology, R&D at Orion Oyj since 2017.
Prior to this, he worked as the Scientific Director at Boneca Oy.
Postes actifs de Heikki Joensuu
| Sociétés | Poste | Début |
|---|---|---|
| ORION OYJ | Corporate Officer/Principal | 01/12/2017 |
Anciens postes connus de Heikki Joensuu
| Sociétés | Poste | Fin |
|---|---|---|
Boneca Oy
 Boneca Oy Medical SpecialtiesHealth Technology The current business of Boneca is to sell BNCT treatments to Finnish and foreign hospitals. The focus of their research work is on clinical trials and their goals are to prove the effectiveness of BNCT treatment and to widen the treatments to tumors located in different areas of the body. They are especially interested in collaborating with companies or research groups manufacturing or developing new compounds targeting specifically to cancer cells and in vivo imaging agents of these compounds. | Chief Tech/Sci/R&D Officer | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ORION OYJ | Health Technology |
| Entreprise privées | 1 |
|---|---|
Boneca Oy
Boneca Oy Medical SpecialtiesHealth Technology The current business of Boneca is to sell BNCT treatments to Finnish and foreign hospitals. The focus of their research work is on clinical trials and their goals are to prove the effectiveness of BNCT treatment and to widen the treatments to tumors located in different areas of the body. They are especially interested in collaborating with companies or research groups manufacturing or developing new compounds targeting specifically to cancer cells and in vivo imaging agents of these compounds. | Health Technology |
